Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis

NCT06809517 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Leptomeningeal Metastasis
Intrathecal Drug Delivery

Interventions

DRUG: AK112
DRUG: Pemetrexed (Alimta)

Sponsor

Guangzhou Medical University